Global Artificial Heart Market
Global Artificial Heart Market

Artificial Heart Comprehensive Study by Type (Ventricular Assist Device (VAD), Total Artificial Heart), End User (Hospitals, Clinics, Research Centers, Others) Players and Region - Global Market Outlook to 2024

Artificial Heart Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Feb 2019 Edition 218 Pages 220 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
An Artificial heart is device that replace original heart and it perform like original heart. It can be consider as prosthetic device fixed into the body to substitute the organic mammalian heart. Person can live with artificial heart from a few weeks to more than one year. Risk associated with treatment for artificial heart implementation because it can lead to bleed and infection.

The market study is being classified by Type (Ventricular Assist Device (VAD) and Total Artificial Heart) and major geographies with country level break-up.

SynCardia Systems (United States), BiVACOR (United States), CARMAT (France), Abbott (United States), Cleveland Heart (United States), AbioMed (United States), Jarvik Heart (United States), Cirtec Medical Systems (United States), Thoratec Corporation (United States), Boston Scientific Corporation (United States) and Braile Biomedica (Brazil) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Colibri Heart Valve LLC (United States), Cryolife Inc. (United States), Edwards Lifesciences Corporation (United States), Heart Leaflet Technology (United States), Jenavalve Technology Inc.(Germany) and Leman Cardiovascular (Switzerland).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Artificial Heart market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Artificial Heart market by Type, Application and Region.

On the basis of geography, the market of Artificial Heart has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Artificial Heart market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Mortality Ratio Due To Cardiovascular Diseases
  • Unhealthy Lifestyle
  • Undesirable Atmospheric Conditions

Market Trend
  • Increasing Awareness about New Technological Innovations
  • Government Initiation towards Providing Funds for Treatment of Heart Dieses

Restraints
  • Expensive Treatment
  • Risk Associated With Transplant Procedure
  • Strict Regulatory Approvals

Opportunities
  • Increasing Healthcare Infrastructure in Emerging Nations

Challenges
  • Need of Skilled Cardiac Specialist
  • Threat of Substitution by using Alternative Methods


On 1st August 2018, CARMAT the designer and developer of the world's most advanced total artificial heart project has announced successful transplant of a donor heart in the first international patient implanted with the CARMAT heart in October 2017. and On 29th May 2018, Boston Scientific Europe has launched the HeartLogic™ Heart Failure Diagnostic in Europe. It provides a diagnostic tool that enables proactive heart failure (HF) care.


Key Target Audience
Artificial heart Suppliers, Artificial heart Manufacturers, Research Laboratories, Medical Devices Industries, Medical Institutes, Government Research Centre and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Ventricular Assist Device (VAD)
  • Total Artificial Heart
By End User
  • Hospitals
  • Clinics
  • Research Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Mortality Ratio Due To Cardiovascular Diseases
      • 3.2.2. Unhealthy Lifestyle
      • 3.2.3. Undesirable Atmospheric Conditions
    • 3.3. Market Challenges
      • 3.3.1. Need of Skilled Cardiac Specialist
      • 3.3.2. Threat of Substitution by using Alternative Methods
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness about New Technological Innovations
      • 3.4.2. Government Initiation towards Providing Funds for Treatment of Heart Dieses
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Heart, by Type, End User and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Artificial Heart (Value)
      • 5.2.1. Global Artificial Heart by: Type (Value)
        • 5.2.1.1. Ventricular Assist Device (VAD)
        • 5.2.1.2. Total Artificial Heart
      • 5.2.2. Global Artificial Heart by: End User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Research Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Artificial Heart Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Artificial Heart (Volume)
      • 5.3.1. Global Artificial Heart by: Type (Volume)
        • 5.3.1.1. Ventricular Assist Device (VAD)
        • 5.3.1.2. Total Artificial Heart
      • 5.3.2. Global Artificial Heart by: End User (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Research Centers
        • 5.3.2.4. Others
      • 5.3.3. Global Artificial Heart Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Artificial Heart (Price)
      • 5.4.1. Global Artificial Heart by: Type (Price)
  • 6. Artificial Heart: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. SynCardia Systems (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BiVACOR (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CARMAT (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cleveland Heart (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AbioMed (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jarvik Heart (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cirtec Medical Systems (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thoratec Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Boston Scientific Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Braile Biomedica (Brazil)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Artificial Heart Sale, by Type, End User and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Artificial Heart (Value)
      • 7.2.1. Global Artificial Heart by: Type (Value)
        • 7.2.1.1. Ventricular Assist Device (VAD)
        • 7.2.1.2. Total Artificial Heart
      • 7.2.2. Global Artificial Heart by: End User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Research Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Artificial Heart Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Artificial Heart (Volume)
      • 7.3.1. Global Artificial Heart by: Type (Volume)
        • 7.3.1.1. Ventricular Assist Device (VAD)
        • 7.3.1.2. Total Artificial Heart
      • 7.3.2. Global Artificial Heart by: End User (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Research Centers
        • 7.3.2.4. Others
      • 7.3.3. Global Artificial Heart Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Artificial Heart (Price)
      • 7.4.1. Global Artificial Heart by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Heart: by Type(USD Million)
  • Table 2. Artificial Heart Ventricular Assist Device (VAD) , by Region USD Million (2013-2018)
  • Table 3. Artificial Heart Total Artificial Heart , by Region USD Million (2013-2018)
  • Table 4. Artificial Heart: by End User(USD Million)
  • Table 5. Artificial Heart Hospitals , by Region USD Million (2013-2018)
  • Table 6. Artificial Heart Clinics , by Region USD Million (2013-2018)
  • Table 7. Artificial Heart Research Centers , by Region USD Million (2013-2018)
  • Table 8. Artificial Heart Others , by Region USD Million (2013-2018)
  • Table 9. South America Artificial Heart, by Country USD Million (2013-2018)
  • Table 10. South America Artificial Heart, by Type USD Million (2013-2018)
  • Table 11. South America Artificial Heart, by End User USD Million (2013-2018)
  • Table 12. Brazil Artificial Heart, by Type USD Million (2013-2018)
  • Table 13. Brazil Artificial Heart, by End User USD Million (2013-2018)
  • Table 14. Argentina Artificial Heart, by Type USD Million (2013-2018)
  • Table 15. Argentina Artificial Heart, by End User USD Million (2013-2018)
  • Table 16. Rest of South America Artificial Heart, by Type USD Million (2013-2018)
  • Table 17. Rest of South America Artificial Heart, by End User USD Million (2013-2018)
  • Table 18. Asia Pacific Artificial Heart, by Country USD Million (2013-2018)
  • Table 19. Asia Pacific Artificial Heart, by Type USD Million (2013-2018)
  • Table 20. Asia Pacific Artificial Heart, by End User USD Million (2013-2018)
  • Table 21. China Artificial Heart, by Type USD Million (2013-2018)
  • Table 22. China Artificial Heart, by End User USD Million (2013-2018)
  • Table 23. Japan Artificial Heart, by Type USD Million (2013-2018)
  • Table 24. Japan Artificial Heart, by End User USD Million (2013-2018)
  • Table 25. India Artificial Heart, by Type USD Million (2013-2018)
  • Table 26. India Artificial Heart, by End User USD Million (2013-2018)
  • Table 27. South Korea Artificial Heart, by Type USD Million (2013-2018)
  • Table 28. South Korea Artificial Heart, by End User USD Million (2013-2018)
  • Table 29. Taiwan Artificial Heart, by Type USD Million (2013-2018)
  • Table 30. Taiwan Artificial Heart, by End User USD Million (2013-2018)
  • Table 31. Australia Artificial Heart, by Type USD Million (2013-2018)
  • Table 32. Australia Artificial Heart, by End User USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Artificial Heart, by Type USD Million (2013-2018)
  • Table 34. Rest of Asia-Pacific Artificial Heart, by End User USD Million (2013-2018)
  • Table 35. Europe Artificial Heart, by Country USD Million (2013-2018)
  • Table 36. Europe Artificial Heart, by Type USD Million (2013-2018)
  • Table 37. Europe Artificial Heart, by End User USD Million (2013-2018)
  • Table 38. Germany Artificial Heart, by Type USD Million (2013-2018)
  • Table 39. Germany Artificial Heart, by End User USD Million (2013-2018)
  • Table 40. France Artificial Heart, by Type USD Million (2013-2018)
  • Table 41. France Artificial Heart, by End User USD Million (2013-2018)
  • Table 42. Italy Artificial Heart, by Type USD Million (2013-2018)
  • Table 43. Italy Artificial Heart, by End User USD Million (2013-2018)
  • Table 44. United Kingdom Artificial Heart, by Type USD Million (2013-2018)
  • Table 45. United Kingdom Artificial Heart, by End User USD Million (2013-2018)
  • Table 46. Netherlands Artificial Heart, by Type USD Million (2013-2018)
  • Table 47. Netherlands Artificial Heart, by End User USD Million (2013-2018)
  • Table 48. Rest of Europe Artificial Heart, by Type USD Million (2013-2018)
  • Table 49. Rest of Europe Artificial Heart, by End User USD Million (2013-2018)
  • Table 50. MEA Artificial Heart, by Country USD Million (2013-2018)
  • Table 51. MEA Artificial Heart, by Type USD Million (2013-2018)
  • Table 52. MEA Artificial Heart, by End User USD Million (2013-2018)
  • Table 53. Middle East Artificial Heart, by Type USD Million (2013-2018)
  • Table 54. Middle East Artificial Heart, by End User USD Million (2013-2018)
  • Table 55. Africa Artificial Heart, by Type USD Million (2013-2018)
  • Table 56. Africa Artificial Heart, by End User USD Million (2013-2018)
  • Table 57. North America Artificial Heart, by Country USD Million (2013-2018)
  • Table 58. North America Artificial Heart, by Type USD Million (2013-2018)
  • Table 59. North America Artificial Heart, by End User USD Million (2013-2018)
  • Table 60. United States Artificial Heart, by Type USD Million (2013-2018)
  • Table 61. United States Artificial Heart, by End User USD Million (2013-2018)
  • Table 62. Canada Artificial Heart, by Type USD Million (2013-2018)
  • Table 63. Canada Artificial Heart, by End User USD Million (2013-2018)
  • Table 64. Mexico Artificial Heart, by Type USD Million (2013-2018)
  • Table 65. Mexico Artificial Heart, by End User USD Million (2013-2018)
  • Table 66. Artificial Heart Sales: by Type(Y)
  • Table 67. Artificial Heart Sales Ventricular Assist Device (VAD) , by Region Y (2013-2018)
  • Table 68. Artificial Heart Sales Total Artificial Heart , by Region Y (2013-2018)
  • Table 69. Artificial Heart Sales: by End User(Y)
  • Table 70. Artificial Heart Sales Hospitals , by Region Y (2013-2018)
  • Table 71. Artificial Heart Sales Clinics , by Region Y (2013-2018)
  • Table 72. Artificial Heart Sales Research Centers , by Region Y (2013-2018)
  • Table 73. Artificial Heart Sales Others , by Region Y (2013-2018)
  • Table 74. South America Artificial Heart Sales, by Country Y (2013-2018)
  • Table 75. South America Artificial Heart Sales, by Type Y (2013-2018)
  • Table 76. South America Artificial Heart Sales, by End User Y (2013-2018)
  • Table 77. Brazil Artificial Heart Sales, by Type Y (2013-2018)
  • Table 78. Brazil Artificial Heart Sales, by End User Y (2013-2018)
  • Table 79. Argentina Artificial Heart Sales, by Type Y (2013-2018)
  • Table 80. Argentina Artificial Heart Sales, by End User Y (2013-2018)
  • Table 81. Rest of South America Artificial Heart Sales, by Type Y (2013-2018)
  • Table 82. Rest of South America Artificial Heart Sales, by End User Y (2013-2018)
  • Table 83. Asia Pacific Artificial Heart Sales, by Country Y (2013-2018)
  • Table 84. Asia Pacific Artificial Heart Sales, by Type Y (2013-2018)
  • Table 85. Asia Pacific Artificial Heart Sales, by End User Y (2013-2018)
  • Table 86. China Artificial Heart Sales, by Type Y (2013-2018)
  • Table 87. China Artificial Heart Sales, by End User Y (2013-2018)
  • Table 88. Japan Artificial Heart Sales, by Type Y (2013-2018)
  • Table 89. Japan Artificial Heart Sales, by End User Y (2013-2018)
  • Table 90. India Artificial Heart Sales, by Type Y (2013-2018)
  • Table 91. India Artificial Heart Sales, by End User Y (2013-2018)
  • Table 92. South Korea Artificial Heart Sales, by Type Y (2013-2018)
  • Table 93. South Korea Artificial Heart Sales, by End User Y (2013-2018)
  • Table 94. Taiwan Artificial Heart Sales, by Type Y (2013-2018)
  • Table 95. Taiwan Artificial Heart Sales, by End User Y (2013-2018)
  • Table 96. Australia Artificial Heart Sales, by Type Y (2013-2018)
  • Table 97. Australia Artificial Heart Sales, by End User Y (2013-2018)
  • Table 98. Rest of Asia-Pacific Artificial Heart Sales, by Type Y (2013-2018)
  • Table 99. Rest of Asia-Pacific Artificial Heart Sales, by End User Y (2013-2018)
  • Table 100. Europe Artificial Heart Sales, by Country Y (2013-2018)
  • Table 101. Europe Artificial Heart Sales, by Type Y (2013-2018)
  • Table 102. Europe Artificial Heart Sales, by End User Y (2013-2018)
  • Table 103. Germany Artificial Heart Sales, by Type Y (2013-2018)
  • Table 104. Germany Artificial Heart Sales, by End User Y (2013-2018)
  • Table 105. France Artificial Heart Sales, by Type Y (2013-2018)
  • Table 106. France Artificial Heart Sales, by End User Y (2013-2018)
  • Table 107. Italy Artificial Heart Sales, by Type Y (2013-2018)
  • Table 108. Italy Artificial Heart Sales, by End User Y (2013-2018)
  • Table 109. United Kingdom Artificial Heart Sales, by Type Y (2013-2018)
  • Table 110. United Kingdom Artificial Heart Sales, by End User Y (2013-2018)
  • Table 111. Netherlands Artificial Heart Sales, by Type Y (2013-2018)
  • Table 112. Netherlands Artificial Heart Sales, by End User Y (2013-2018)
  • Table 113. Rest of Europe Artificial Heart Sales, by Type Y (2013-2018)
  • Table 114. Rest of Europe Artificial Heart Sales, by End User Y (2013-2018)
  • Table 115. MEA Artificial Heart Sales, by Country Y (2013-2018)
  • Table 116. MEA Artificial Heart Sales, by Type Y (2013-2018)
  • Table 117. MEA Artificial Heart Sales, by End User Y (2013-2018)
  • Table 118. Middle East Artificial Heart Sales, by Type Y (2013-2018)
  • Table 119. Middle East Artificial Heart Sales, by End User Y (2013-2018)
  • Table 120. Africa Artificial Heart Sales, by Type Y (2013-2018)
  • Table 121. Africa Artificial Heart Sales, by End User Y (2013-2018)
  • Table 122. North America Artificial Heart Sales, by Country Y (2013-2018)
  • Table 123. North America Artificial Heart Sales, by Type Y (2013-2018)
  • Table 124. North America Artificial Heart Sales, by End User Y (2013-2018)
  • Table 125. United States Artificial Heart Sales, by Type Y (2013-2018)
  • Table 126. United States Artificial Heart Sales, by End User Y (2013-2018)
  • Table 127. Canada Artificial Heart Sales, by Type Y (2013-2018)
  • Table 128. Canada Artificial Heart Sales, by End User Y (2013-2018)
  • Table 129. Mexico Artificial Heart Sales, by Type Y (2013-2018)
  • Table 130. Mexico Artificial Heart Sales, by End User Y (2013-2018)
  • Table 131. Artificial Heart: by Type(USD/Units)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Artificial Heart: by Type(USD Million)
  • Table 144. Artificial Heart Ventricular Assist Device (VAD) , by Region USD Million (2019-2024)
  • Table 145. Artificial Heart Total Artificial Heart , by Region USD Million (2019-2024)
  • Table 146. Artificial Heart: by End User(USD Million)
  • Table 147. Artificial Heart Hospitals , by Region USD Million (2019-2024)
  • Table 148. Artificial Heart Clinics , by Region USD Million (2019-2024)
  • Table 149. Artificial Heart Research Centers , by Region USD Million (2019-2024)
  • Table 150. Artificial Heart Others , by Region USD Million (2019-2024)
  • Table 151. South America Artificial Heart, by Country USD Million (2019-2024)
  • Table 152. South America Artificial Heart, by Type USD Million (2019-2024)
  • Table 153. South America Artificial Heart, by End User USD Million (2019-2024)
  • Table 154. Brazil Artificial Heart, by Type USD Million (2019-2024)
  • Table 155. Brazil Artificial Heart, by End User USD Million (2019-2024)
  • Table 156. Argentina Artificial Heart, by Type USD Million (2019-2024)
  • Table 157. Argentina Artificial Heart, by End User USD Million (2019-2024)
  • Table 158. Rest of South America Artificial Heart, by Type USD Million (2019-2024)
  • Table 159. Rest of South America Artificial Heart, by End User USD Million (2019-2024)
  • Table 160. Asia Pacific Artificial Heart, by Country USD Million (2019-2024)
  • Table 161. Asia Pacific Artificial Heart, by Type USD Million (2019-2024)
  • Table 162. Asia Pacific Artificial Heart, by End User USD Million (2019-2024)
  • Table 163. China Artificial Heart, by Type USD Million (2019-2024)
  • Table 164. China Artificial Heart, by End User USD Million (2019-2024)
  • Table 165. Japan Artificial Heart, by Type USD Million (2019-2024)
  • Table 166. Japan Artificial Heart, by End User USD Million (2019-2024)
  • Table 167. India Artificial Heart, by Type USD Million (2019-2024)
  • Table 168. India Artificial Heart, by End User USD Million (2019-2024)
  • Table 169. South Korea Artificial Heart, by Type USD Million (2019-2024)
  • Table 170. South Korea Artificial Heart, by End User USD Million (2019-2024)
  • Table 171. Taiwan Artificial Heart, by Type USD Million (2019-2024)
  • Table 172. Taiwan Artificial Heart, by End User USD Million (2019-2024)
  • Table 173. Australia Artificial Heart, by Type USD Million (2019-2024)
  • Table 174. Australia Artificial Heart, by End User USD Million (2019-2024)
  • Table 175. Rest of Asia-Pacific Artificial Heart, by Type USD Million (2019-2024)
  • Table 176. Rest of Asia-Pacific Artificial Heart, by End User USD Million (2019-2024)
  • Table 177. Europe Artificial Heart, by Country USD Million (2019-2024)
  • Table 178. Europe Artificial Heart, by Type USD Million (2019-2024)
  • Table 179. Europe Artificial Heart, by End User USD Million (2019-2024)
  • Table 180. Germany Artificial Heart, by Type USD Million (2019-2024)
  • Table 181. Germany Artificial Heart, by End User USD Million (2019-2024)
  • Table 182. France Artificial Heart, by Type USD Million (2019-2024)
  • Table 183. France Artificial Heart, by End User USD Million (2019-2024)
  • Table 184. Italy Artificial Heart, by Type USD Million (2019-2024)
  • Table 185. Italy Artificial Heart, by End User USD Million (2019-2024)
  • Table 186. United Kingdom Artificial Heart, by Type USD Million (2019-2024)
  • Table 187. United Kingdom Artificial Heart, by End User USD Million (2019-2024)
  • Table 188. Netherlands Artificial Heart, by Type USD Million (2019-2024)
  • Table 189. Netherlands Artificial Heart, by End User USD Million (2019-2024)
  • Table 190. Rest of Europe Artificial Heart, by Type USD Million (2019-2024)
  • Table 191. Rest of Europe Artificial Heart, by End User USD Million (2019-2024)
  • Table 192. MEA Artificial Heart, by Country USD Million (2019-2024)
  • Table 193. MEA Artificial Heart, by Type USD Million (2019-2024)
  • Table 194. MEA Artificial Heart, by End User USD Million (2019-2024)
  • Table 195. Middle East Artificial Heart, by Type USD Million (2019-2024)
  • Table 196. Middle East Artificial Heart, by End User USD Million (2019-2024)
  • Table 197. Africa Artificial Heart, by Type USD Million (2019-2024)
  • Table 198. Africa Artificial Heart, by End User USD Million (2019-2024)
  • Table 199. North America Artificial Heart, by Country USD Million (2019-2024)
  • Table 200. North America Artificial Heart, by Type USD Million (2019-2024)
  • Table 201. North America Artificial Heart, by End User USD Million (2019-2024)
  • Table 202. United States Artificial Heart, by Type USD Million (2019-2024)
  • Table 203. United States Artificial Heart, by End User USD Million (2019-2024)
  • Table 204. Canada Artificial Heart, by Type USD Million (2019-2024)
  • Table 205. Canada Artificial Heart, by End User USD Million (2019-2024)
  • Table 206. Mexico Artificial Heart, by Type USD Million (2019-2024)
  • Table 207. Mexico Artificial Heart, by End User USD Million (2019-2024)
  • Table 208. Artificial Heart Sales: by Type(Y)
  • Table 209. Artificial Heart Sales Ventricular Assist Device (VAD) , by Region Y (2019-2024)
  • Table 210. Artificial Heart Sales Total Artificial Heart , by Region Y (2019-2024)
  • Table 211. Artificial Heart Sales: by End User(Y)
  • Table 212. Artificial Heart Sales Hospitals , by Region Y (2019-2024)
  • Table 213. Artificial Heart Sales Clinics , by Region Y (2019-2024)
  • Table 214. Artificial Heart Sales Research Centers , by Region Y (2019-2024)
  • Table 215. Artificial Heart Sales Others , by Region Y (2019-2024)
  • Table 216. South America Artificial Heart Sales, by Country Y (2019-2024)
  • Table 217. South America Artificial Heart Sales, by Type Y (2019-2024)
  • Table 218. South America Artificial Heart Sales, by End User Y (2019-2024)
  • Table 219. Brazil Artificial Heart Sales, by Type Y (2019-2024)
  • Table 220. Brazil Artificial Heart Sales, by End User Y (2019-2024)
  • Table 221. Argentina Artificial Heart Sales, by Type Y (2019-2024)
  • Table 222. Argentina Artificial Heart Sales, by End User Y (2019-2024)
  • Table 223. Rest of South America Artificial Heart Sales, by Type Y (2019-2024)
  • Table 224. Rest of South America Artificial Heart Sales, by End User Y (2019-2024)
  • Table 225. Asia Pacific Artificial Heart Sales, by Country Y (2019-2024)
  • Table 226. Asia Pacific Artificial Heart Sales, by Type Y (2019-2024)
  • Table 227. Asia Pacific Artificial Heart Sales, by End User Y (2019-2024)
  • Table 228. China Artificial Heart Sales, by Type Y (2019-2024)
  • Table 229. China Artificial Heart Sales, by End User Y (2019-2024)
  • Table 230. Japan Artificial Heart Sales, by Type Y (2019-2024)
  • Table 231. Japan Artificial Heart Sales, by End User Y (2019-2024)
  • Table 232. India Artificial Heart Sales, by Type Y (2019-2024)
  • Table 233. India Artificial Heart Sales, by End User Y (2019-2024)
  • Table 234. South Korea Artificial Heart Sales, by Type Y (2019-2024)
  • Table 235. South Korea Artificial Heart Sales, by End User Y (2019-2024)
  • Table 236. Taiwan Artificial Heart Sales, by Type Y (2019-2024)
  • Table 237. Taiwan Artificial Heart Sales, by End User Y (2019-2024)
  • Table 238. Australia Artificial Heart Sales, by Type Y (2019-2024)
  • Table 239. Australia Artificial Heart Sales, by End User Y (2019-2024)
  • Table 240. Rest of Asia-Pacific Artificial Heart Sales, by Type Y (2019-2024)
  • Table 241. Rest of Asia-Pacific Artificial Heart Sales, by End User Y (2019-2024)
  • Table 242. Europe Artificial Heart Sales, by Country Y (2019-2024)
  • Table 243. Europe Artificial Heart Sales, by Type Y (2019-2024)
  • Table 244. Europe Artificial Heart Sales, by End User Y (2019-2024)
  • Table 245. Germany Artificial Heart Sales, by Type Y (2019-2024)
  • Table 246. Germany Artificial Heart Sales, by End User Y (2019-2024)
  • Table 247. France Artificial Heart Sales, by Type Y (2019-2024)
  • Table 248. France Artificial Heart Sales, by End User Y (2019-2024)
  • Table 249. Italy Artificial Heart Sales, by Type Y (2019-2024)
  • Table 250. Italy Artificial Heart Sales, by End User Y (2019-2024)
  • Table 251. United Kingdom Artificial Heart Sales, by Type Y (2019-2024)
  • Table 252. United Kingdom Artificial Heart Sales, by End User Y (2019-2024)
  • Table 253. Netherlands Artificial Heart Sales, by Type Y (2019-2024)
  • Table 254. Netherlands Artificial Heart Sales, by End User Y (2019-2024)
  • Table 255. Rest of Europe Artificial Heart Sales, by Type Y (2019-2024)
  • Table 256. Rest of Europe Artificial Heart Sales, by End User Y (2019-2024)
  • Table 257. MEA Artificial Heart Sales, by Country Y (2019-2024)
  • Table 258. MEA Artificial Heart Sales, by Type Y (2019-2024)
  • Table 259. MEA Artificial Heart Sales, by End User Y (2019-2024)
  • Table 260. Middle East Artificial Heart Sales, by Type Y (2019-2024)
  • Table 261. Middle East Artificial Heart Sales, by End User Y (2019-2024)
  • Table 262. Africa Artificial Heart Sales, by Type Y (2019-2024)
  • Table 263. Africa Artificial Heart Sales, by End User Y (2019-2024)
  • Table 264. North America Artificial Heart Sales, by Country Y (2019-2024)
  • Table 265. North America Artificial Heart Sales, by Type Y (2019-2024)
  • Table 266. North America Artificial Heart Sales, by End User Y (2019-2024)
  • Table 267. United States Artificial Heart Sales, by Type Y (2019-2024)
  • Table 268. United States Artificial Heart Sales, by End User Y (2019-2024)
  • Table 269. Canada Artificial Heart Sales, by Type Y (2019-2024)
  • Table 270. Canada Artificial Heart Sales, by End User Y (2019-2024)
  • Table 271. Mexico Artificial Heart Sales, by Type Y (2019-2024)
  • Table 272. Mexico Artificial Heart Sales, by End User Y (2019-2024)
  • Table 273. Artificial Heart: by Type(USD/Units)
  • Table 274. Research Programs/Design for This Report
  • Table 275. Key Data Information from Secondary Sources
  • Table 276. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Heart: by Type USD Million (2013-2018)
  • Figure 5. Global Artificial Heart: by End User USD Million (2013-2018)
  • Figure 6. South America Artificial Heart Share (%), by Country
  • Figure 7. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 8. Europe Artificial Heart Share (%), by Country
  • Figure 9. MEA Artificial Heart Share (%), by Country
  • Figure 10. North America Artificial Heart Share (%), by Country
  • Figure 11. Global Artificial Heart: by Type Y (2013-2018)
  • Figure 12. Global Artificial Heart: by End User Y (2013-2018)
  • Figure 13. South America Artificial Heart Share (%), by Country
  • Figure 14. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 15. Europe Artificial Heart Share (%), by Country
  • Figure 16. MEA Artificial Heart Share (%), by Country
  • Figure 17. North America Artificial Heart Share (%), by Country
  • Figure 18. Global Artificial Heart: by Type USD/Units (2013-2018)
  • Figure 19. Global Artificial Heart share by Players 2018 (%)
  • Figure 20. Global Artificial Heart share by Players (Top 3) 2018(%)
  • Figure 21. Global Artificial Heart share by Players (Top 5) 2018(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. SynCardia Systems (United States) Revenue, Net Income and Gross profit
  • Figure 24. SynCardia Systems (United States) Revenue: by Geography 2018
  • Figure 25. BiVACOR (United States) Revenue, Net Income and Gross profit
  • Figure 26. BiVACOR (United States) Revenue: by Geography 2018
  • Figure 27. CARMAT (France) Revenue, Net Income and Gross profit
  • Figure 28. CARMAT (France) Revenue: by Geography 2018
  • Figure 29. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott (United States) Revenue: by Geography 2018
  • Figure 31. Cleveland Heart (United States) Revenue, Net Income and Gross profit
  • Figure 32. Cleveland Heart (United States) Revenue: by Geography 2018
  • Figure 33. AbioMed (United States) Revenue, Net Income and Gross profit
  • Figure 34. AbioMed (United States) Revenue: by Geography 2018
  • Figure 35. Jarvik Heart (United States) Revenue, Net Income and Gross profit
  • Figure 36. Jarvik Heart (United States) Revenue: by Geography 2018
  • Figure 37. Cirtec Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cirtec Medical Systems (United States) Revenue: by Geography 2018
  • Figure 39. Thoratec Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Thoratec Corporation (United States) Revenue: by Geography 2018
  • Figure 41. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Boston Scientific Corporation (United States) Revenue: by Geography 2018
  • Figure 43. Braile Biomedica (Brazil) Revenue, Net Income and Gross profit
  • Figure 44. Braile Biomedica (Brazil) Revenue: by Geography 2018
  • Figure 45. Global Artificial Heart: by Type USD Million (2013-2018)
  • Figure 46. Global Artificial Heart: by End User USD Million (2013-2018)
  • Figure 47. South America Artificial Heart Share (%), by Country
  • Figure 48. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 49. Europe Artificial Heart Share (%), by Country
  • Figure 50. MEA Artificial Heart Share (%), by Country
  • Figure 51. North America Artificial Heart Share (%), by Country
  • Figure 52. Global Artificial Heart: by Type Y (2013-2018)
  • Figure 53. Global Artificial Heart: by End User Y (2013-2018)
  • Figure 54. South America Artificial Heart Share (%), by Country
  • Figure 55. Asia Pacific Artificial Heart Share (%), by Country
  • Figure 56. Europe Artificial Heart Share (%), by Country
  • Figure 57. MEA Artificial Heart Share (%), by Country
  • Figure 58. North America Artificial Heart Share (%), by Country
  • Figure 59. Global Artificial Heart: by Type USD/Units (2013-2018)
Some of the key companies/manufacturers profiled in the report
  • SynCardia Systems (United States)
  • BiVACOR (United States)
  • CARMAT (France)
  • Abbott (United States)
  • Cleveland Heart (United States)
  • AbioMed (United States)
  • Jarvik Heart (United States)
  • Cirtec Medical Systems (United States)
  • Thoratec Corporation (United States)
  • Boston Scientific Corporation (United States)
  • Braile Biomedica (Brazil)
Additional players considered in the study are as follows:
Colibri Heart Valve LLC (United States) , Cryolife Inc. (United States) , Edwards Lifesciences Corporation (United States) , Heart Leaflet Technology (United States) , Jenavalve Technology Inc.(Germany) , Leman Cardiovascular (Switzerland)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation